BioCentury
ARTICLE | Company News

Management tracks: Akari, Turnstone, Iconic

August 22, 2017 11:48 PM UTC

Autoimmune and inflammatory disease company Akari Therapeutics plc (NASDAQ:AKTX) named David Horn Solomon CEO, effective Aug. 28. He was managing partner at Sund Capital, and was previously CEO of Zealand Pharma A/S (CSE:ZEAL; NASDAQ:ZEAL) and Bionor Pharma ASA which Solon Eiendom ASA (OSE:SOLON) acquired.

Cancer company Turnstone Biologics Inc. (Ottawa, Ontario) named Kris Elverum CBO. He was CBO of SQZ Biotechnologies Co. (Boston, Mass.)...